Portfolio company
Hy2Care
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops injectable hydrogel implants that facilitate natural cartilage repair for patients with joint injuries to prevent osteoarthritis.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Hyalex Orthopaedics
This company develops synthetic cartilage and implant systems to restore damaged joint surfaces for patients with osteoarthritis or cartilage injuries.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
ALLEGRO
This company develops nanotechnology-based injectable hydrogel devices to treat osteoarthritis in human and veterinary patients.
Atro Medical
This company develops synthetic meniscus prostheses to restore knee function and relieve pain for patients with chronic knee injuries.
Gentis
This company developed an injectable biomaterial implant to restore biomechanical function in degenerated spinal discs for patients with spinal disc disease.
STENTiT
The company develops biodegradable endovascular implants that promote vascular tissue regeneration to treat patients suffering from cardiovascular diseases like peripheral artery disease.
EpiBone
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.
Miach Orthopaedics
This company develops bio-engineered surgical implants to facilitate natural healing of torn anterior cruciate ligaments for patients with knee injuries.
